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Maternal Lifestyle Factors and Fetal Macrosomia Risk: A Review. 
Kathy M. Redfern, Gail A. Rees and Jonathan H. Pinkney.  
Abstract: 
Fetal macrosomia is associated with a number of health complications for both mother and 
infant in the immediate, short and long term.  Maternal obesity and excessive gestational 
weight gain have long been associated with fetal macrosomia, however, the impact of 
maternal lifestyle factors such as dietary intake and energy balance, in combination with the 
timing and composition of weight gain have been less studied. It is also clear that although 
maternal obesity and excessive gestational weight gain increase the risk of fetal macrosomia 
independently, the risk is magnified with the presence of both risk factors, suggesting that 
interventions to control gestational weight gain may be particularly important for obese 
women. Association studies examining the relationship between fetal nutrient availability, 
epigenetic modifications and infant anthropometrics are also required. This review provides 
an overview of the current evidence examining the role of maternal lifestyle factors on the 
prevalence of fetal macrosomia and identifies areas where further research is required in 
order to inform the design of appropriate intervention strategies. 
Keywords: Birth weight, body composition, gestational weight gain, 
macrosomia, maternal obesity. 
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Birth weight is a key determinant of infant health which appears to be determined by a 
complex interaction of maternal and fetal factors. These probably include maternal genetic, 
environmental and lifestyle factors, in conjunction with fetal genetic and intrauterine 
environmental factors. Macrosomia is generally defined as a birth weight greater than 
4000g or 4500g, irrespective of gestational age1, while large for gestational age (LGA) is 
defined as a birth weight >90th percentile as per gestational age2.  
Excessive fetal growth results in increased immediate, short term and long term risks for 
both mother and infant. Macrosomia increases the risk of complications during delivery 
such as birth asphyxia and shoulder dystocia, and also carries an increased risk of delivery 
via caesarean section, which carries its own adverse risks to both neonate and mother3. 
Furthermore, higher birth weight is also associated with increased risk of obesity4 and 
metabolic syndrome5 into childhood, which pose serious long term health risks.  
Numerous maternal factors such as  body mass index (BMI), gestational weight gain (GWG), 
diet, physical activity and the development of gestational diabetes have been shown to 
impact infant birth weight, however previous studies have tended to examine these factors 
individually, and their interaction less so. The purpose of this review is to critically appraise 
the current literature and highlight areas where further research is required to inform 
appropriate maternal intervention strategies, with the aim of improving the health of 
newborn offspring.  
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Maternal Weight 
When examined individually, maternal pre-pregnancy BMI tends to be strongly associated 
with an increased risk of macrosomia.  Numerous studies have observed women classified 
by their BMI as obese to be at significantly greater risk of macrosomia compared with 
women classified as having a healthy weight,6,7 with risk increasing as BMI increases beyond 
the healthy range8  A recent systematic review and meta-analysis conducted by Gaudet and 
colleagues1 showed a positive relationship between maternal obesity and fetal overgrowth 
as defined by birth weight ≥ 4000g, ≥ 4500g and ≥ 90th percentile for gestational age.  
Similarly, excessive GWG has been shown to increase risk of macrosomia9-11 and so, 
although it seems clear that both maternal obesity and excess GWG independently increase 
the risk of macrosomia, the interaction between the two factors is less clear. Crane et al.12 
conducted a retrospective cohort study evaluating the effects of GWG on maternal and 
neonatal outcomes in different BMI classes. In keeping with findings from previous studies6-8 
they observed that overweight and obese mothers were significantly more likely to give 
birth to a macrosomic infant (birth weight ≥ 4000g and adjusted for gestational age) and 
also more likely to gain excess weight than healthy weight mothers. However, when the 
impact of GWG on risk of macrosomic infant was examined by BMI class, risk increased with 
excess GWG for all BMI classes suggesting that when excessive GWG does occur, the risk of 
macrosomia increases regardless of pre-pregnancy BMI. A major limitation of this study was 
that it was retrospective, and so pre-pregnancy BMI or GWG data were missing for 47.8% of 
women. Nohr et al.13 conducted a similar study reporting that BMI category was a stronger 
predictor of LGA neonate than GWG, but that very high GWG (defined as >20kg) increased 
the absolute risk of LGA neonate across all BMI categories. Limitations of the study were 
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that pre-pregnancy weight, height and GWG were self-reported , the reliability of which has 
been disputed14. In addition to examining the effect of maternal obesity and GWG on infant 
birth weight, Carlsen and colleagues15 included neonatal body composition as an outcome 
measure.  They observed that infants born to obese mothers were heavier than infants born 
to healthy weight mothers, and this was exclusively due to increased adiposity. GWG on the 
other hand, was found to increase both fat mass, abdominal fat mass and fat free mass. 
Obese mothers were more likely to exhibit excessive GWG, thereby suggesting these 
women as a particularly important target group to receive an intervention with an aim of 
reducing fetal macrosomia.  
The effect of GWG on maternal and neonatal outcomes in women classified as having a 
healthy pre-pregnancy BMI was examined by Deruelle and colleagues16. Although most 
neonatal outcomes were similar between GWG groups, mean birth weight was significantly 
greater in women with ≥18kg GWG than women gaining 9-15kg, while the proportion of 
macrosomic neonates more than doubled for women with ≥18kg GWG compared those 
gaining 9-15kg (12.1% vs. 5.2%, P<0.03). Prevention of excess GWG in women of healthy 
pre-pregnancy BMI is therefore also important, just as in overweight or obese mothers.  In 
2009, the Institute of Medicine (IOM) published a new set of guidelines on GWG to replace 
those previously published in 199011 and now make recommendations based on pre-
pregnancy BMI category for total and rate of weight gain.   
 is suggested that birth weight, and early childhood growth patterns can lead to a 
predisposition to childhood obesity, with the potential to persist into adolescence and 
adulthood17. In a diverse sample of US women, adequate GWG, when compared with 
inadequate weight gain, was associated with significantly increased odds of infants being 
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born small for gestational age (SGA), while excessive gain was significantly associated with 
decreased odds of SGA and more than doubled the risk of LGA18. Excessive GWG also 
significantly increased the risk of child overweight or obesity (BMI ≥ 85th percentile) when 
followed up between the ages of 2 and 20 years. For overweight and obese women, 
predicted probabilities of LGA and childhood overweight were higher than those for 
underweight or healthy weight women, regardless of GWG.  Increased GWG was 
significantly associated with increased probability of LGA and child overweight across all 
BMI groups. Similarly, a retrospective cohort of 499 mother-child dyads19 observed that 
maternal morbid obesity (BMI ≥40 kg/m2) was significantly associated with infant birth 
weight and weight for length throughout the first 3 months of life, and that these 
associations were significantly amplified by excess GWG. At 12 months of age these effects 
were sustained, with infants of morbidly obese mothers exhibiting an 8.4% higher weight 
for length percentile compared with infants of mothers with a BMI of 25 kg/m2. Infants born 
to mothers with a healthy BMI, but with excess GWG normalised their growth by 12 months 
of age.  
These findings suggest that babies born to women in all BMI categories are at risk of 
increased birth weight and elevated weight during early life as a result of excessive GWG, 
but that overweight and obese women are of particular concern, as their risk appears to be 
amplified15,19. Future studies, particularly of a prospective nature should therefore perhaps 
focus on this group of women in order to develop a wider understanding of lifestyle factors 
that contribute to excess GWG.  
Maternal Body Composition: 
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Although BMI is widely used to provide estimates of body composition, it is not without its 
limitations. Prentice & Jebb20 propose that obesity should be defined as the excess 
accumulation of body fat, whereas BMI identifies the presence of excess body weight, which 
also reflects lean body mass. Krentz et al.21 compared birth weight outcomes for women 
with the same BMI, but two different heights in a retrospective cohort study. They observed 
differences in birth weights and birth weight classification by gestational age between 
groups, which once again provides evidence to suggest the limited utility of BMI as a 
predictor of neonatal outcomes. In addition, GWG is typically reported as a single measure 
of mass gained during pregnancy, with the individual effects of fat mass and fat-free mass 
gains left undefined. It therefore seems prudent to examine the contributions of changes to 
estimated maternal fat mass and fat free mass on pregnancy outcomes, in addition to total 
GWG and maternal obesity defined by BMI.  
As might be expected, maternal weight, fat-free mass and fat mass increased between 28 
and 37 weeks gestation in a recent prospective cohort study examining maternal body 
composition, however, birth weight significantly correlated with maternal fat-free mass and 
not fat mass22. In a similar study fat-free mass, but not fat mass was also a significant 
predictor of birth weight, and after adjustment for confounding variables, mothers in the 
highest fat-free mass quartile were at significantly higher risk of infant macrosomia, 
compared with mothers in the lowest quartile23. However, this study measured body 
composition only in the first trimester. Butte et al.24 partitioned GWG into fat mass, fat-free 
mass, total body water and protein gains as assessed at weeks 9, 22 and 36 of gestation. 
Infant birth weight was found to correlate significantly with fat-free mass (r= 0.39, P=0.003) 
and total body water (r= 0.37, P=0.006), but not fat mass (r= 0.05, P = 0.76). These studies 
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suggest fat-free mass, and not fat mass mediates an increase in infant birth weight. It is 
hypothesised that these positive associations between maternal fat free mass and infant 
birth weight may be due to maternal plasma volume expansion25, which is in turn influenced 
by maternal hormonal changes26. 
Forsum et al.27 addressed the hypothesis that maternal body fat stimulates fetal growth and 
fat deposition. In a small, observational study they assessed infant subcutaneous adipose 
tissue volume in vivo using magnetic resonance imaging, while maternal body composition 
was assessed using a two-compartment model based on total body water. It was observed 
that maternal total body fat before pregnancy and at 32 weeks gestation were significantly 
and positively correlated with infant birth weight, while in infants, birth weight positively 
correlated with subcutaneous adipose tissue.  
Further studies examining the effects of maternal body composition on neonatal body 
composition and incidence of macrosomia are therefore required in order to fully 
understand the relationship between the composition of GWG and infant birth size.   
Timing of Gestational Weight Gain: 
Although the influence of total GWG during pregnancy has been well documented, the 
timing of overnutrition and subsequent weight gain has not been examined as thoroughly. 
This could be an important factor in the design of any intervention studies. Davenport et 
al.28 evaluated whether the timing of excessive GWG in pregnant women following current 
healthy living guidelines affected neonatal adiposity at birth in their prospective cohort 
study.  The cohort were retrospectively grouped according to IOM guidelines11 for weight 
gain in the first and second halves of pregnancy. Infants born to women who exhibited 
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excessive GWG during the first half of pregnancy exhibited greater birth weight, crown-heel 
length and excessive neonatal body fat compared with infants born to women who 
exhibited appropriate GWG in the first half of pregnancy. These differences remained 
significant after controlling for BMI, total GWG, maternal age, gestational age and neonatal 
sex. Farah et al.22 conducted a longitudinal prospective observational study which observed 
that birth weight was significantly correlated with GWG before the third trimester (r=0.163, 
P=0.027) but not with total or third trimester GWG. These studies suggest that neonatal 
adiposity is potentially more strongly influenced by timing of GWG than total GWG, 
suggesting a direct link between the early intrauterine environment and subsequent 
neonatal adiposity. However, the data on timing of GWG and its influence on neonatal 
weight and adiposity is limited. Studies examining weight change during pregnancy at 
frequent assessments are therefore required in order to increase our understanding of the 
mechanism by which maternal obesity and GWG influence infant birth weight and body 
composition.  
Gestational Diabetes Mellitus: 
Gestational diabetes mellitus (GDM) is a common metabolic complication of pregnancy, 
defined as glucose intolerance with first onset or recognition during pregnancy29. GDM is 
most frequently observed amongst overweight or obese women30 as these women are 
more likely to exhibit impaired glucose tolerance and decreased insulin sensitivity before 
and during pregnancy31 when compared with women of a healthy weight. Infants born to 
women with GDM are often characterised by excessive fetal growth and subsequently tend 
to be at increased risk of macrosomia31. However, even in the absence of increased body 
mass, studies have shown that infants born to mothers with GDM exhibit increases in fat 
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mass, but not fat-free mass when compared with women with normal glucose tolerance32,33. 
Results from the hyperglycaemia and adverse pregnancy outcome (HAPO) study observed 
an increase in neonatal adiposity associated with increasing maternal glucose 
concentrations, less than those used to define GDM34. Physical activity has also been shown 
to influence glucose metabolism and transport via insulin-independent pathways, and has 
been associated with a decreased incidence of GDM in epidemiological studies35. 
Maternal Energy Intake and Expenditure:  
Clearly nutritional status prior to and during pregnancy is essential for the growth and 
development of the foetus, with excessive GWG and adverse pregnancy outcomes also 
largely influenced by dietary intake, either as nutrient excess, nutrient deficiencies or by 
indirectly influencing the intrauterine environment.  
A study by Knudson et al.36 supports the theory that maternal glucose metabolism may 
impact fetal growth. They examined the associations between maternal glycaemic load, 
GWG, birth weight and risk of LGA neonate as part of the Danish National Birth Cohort. They 
observed that the risk of LGA neonate increased by 14% for the highest glycaemic load 
quintile, compared with the lowest quintile.  A randomised controlled trial examining the 
impact of a low glycaemic index diet on neonatal anthropometry observed a decrease in 
neonatal thigh circumference for the intervention group when compared with a control 
group, although no differences were observed for any skinfold measurements nor head, 
abdominal or mid-upper arm circumferences37.  
In a prospective study, GWG was significantly and positively associated with energy intake 
and energy-adjusted intakes of lipids from animal origin and protein, while a significant 
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inverse association was observed between carbohydrate intake and GWG, but these were 
not significantly related to birth size38.  Olsen et al.39 observed that milk consumption during 
pregnancy was inversely associated with SGA, and directly associated with LGA and mean 
birth weight. Women consuming ≥ 6 glasses of milk/day had increased risk of LGA infants 
when compared with women who reported no milk consumption. When fat and protein 
intakes from dairy products (excluding cheese and ice cream) were examined, no 
association between birth weight and fat intake was found, while a positive association 
between protein intake and birth weight was observed. The authors proposed that the 
positive association between milk consumption and birth weight is driven by the presence 
of insulin-like growth factor-1 in both low-fat and whole-milk products. Montpetit et al.40 
examined the contribution of pre-pregnancy BMI, energy intake and physical activity as 
determinants of GWG and infant birth weight. Energy intake was the only significant 
predictor of infant birth weight. Steps per day were inversely associated with GWG, 
although when pre-pregnancy BMI was added to the model, steps were no longer significant 
and BMI remained the only significant variable. 
 
A U.S. study41 observed decreases in birth weight and LGA births between 2000 and 2005, 
trends which did not appear to be explained by routinely recorded maternal characteristics. 
The authors hypothesised that other maternal characteristics such as maternal diet, physical 
activity or socioeconomic factors may have contributed to the trends observed and called 
for detailed studies of smaller populations to explore the role of these factors.    
Furthermore, the rapidly expanding field of epigenetic epidemiology has observed 
numerous associations between fetal nutrient availability and epigenetic modifications42. 
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Differences in the methylation status of candidate genes have been observed in relation to 
fetal growth43 and later childhood adiposity,44,45 however, human studies examining specific 
intrauterine nutritional exposures and subsequent adiposity at birth and during childhood 
are scarce. Studies of an observational and epigenetic nature are therefore essential for 
increasing our understanding of how nutritional exposures influence GWG and infant 
phenotypic outcomes.  
Conclusion: 
It is important to gain an understanding of the factors influencing neonatal anthropometric 
outcomes, as macrosomic infants with or without excess adiposity at birth have been shown 
to be at increased risk of adverse consequences such as insulin resistance,46,47 metabolic 
syndrome5 and childhood obesity4,48. As observed from the current literature, there is 
consistent evidence to suggest that maternal obesity and excess GWG alongside GDM 
contribute to increased risk of adverse neonatal anthropometric outcomes,12,13 hence 
current pregnancy interventions already aim to reduce the prevalence of these risk factors. . 
However, maternal obesity and GWG are broad outcome measures. Recent studies suggest 
maternal body composition, and timing of GWG may influence infant anthropometrics 
independently of maternal BMI and total GWG which may offer an increased understanding 
of the mechanisms by which maternal obesity and GWG influence neonatal anthropometric 
outcomes. At present, data in this area is limited22,23,28 and there is also a lack of recent 
prospective studies examining the effects of GWG by BMI according to the most recent IOM 
recommendations11.  
Maternal diet and energy balance during pregnancy undoubtedly influence GWG and 
subsequent anthropometric outcomes for offspring. However, despite a wealth of studies 
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linking maternal energy intake to GWG,38,49 and maternal dietary glucose intake to neonatal 
anthropometry,36,37 few studies have examined the impact of other nutrients in the 
maternal diet, nor energy balance together with physical activity. Studies examining 
nutritional exposures during pregnancy and epigenetic modifications in offspring are also 
required50.  
The contributions of various maternal lifestyle factors to fetal macrosomia from the current 
literature are summarised in Table 1. However, as discussed, there are gaps in the current 
literature, as well as conflicting findings. It is therefore necessary to examine further the 
independent and moderating effects of maternal dietary intake, physical activity and the 
timing and composition of GWG, on neonatal anthropometric outcomes in future studies. 
Such studies could provide a more complete picture of the maternal lifestyle factors 
contributing to GWG, neonatal body composition and potentially, future offspring health, 
thus allowing health professionals to develop suitable and effective interventions to 
improve birth and health outcomes for both mother and infant. In the meantime, pregnant 
women should be advised to adhere to IOM guidelines for weight gain11 and offered 
nutritional support if necessary. Particularly close attention should be paid to women 
entering their pregnancy with a BMI ≥30, as offspring of these women appear to be at 
increased risk of macrosomia, regardless of the contribution of other potential risk factors 
yet to be investigated.  
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Table 1. The contributions of maternal lifestyle factors to risk of macrosomia.  
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